Among ‘responders’, the magnitude of the CD4+ T cell response was comparable in the ICC and ImCO patient groups, with no significant differences in the frequencies of antigen-specific CD4+ T cells at <30 days (Figure 3C). The gene discussed is CD4; the disease is intrahepatic cholangiocarcinoma.